Critical Assessment of Risk Factors for Complications After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei

By Saxena Akshat  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1291-1301

Springer Publishing Company

Access to resources Recommend Favorite

Determining the Association Between Preoperative Computed Tomography Findings and Postoperative Outcomes After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei

By Chua Terence  

Annals of Surgical Oncology, Vol. 18, Iss. 6, 2011-06 ,pp. : 1582-1589

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

By Baratti Dario   Kusamura Shigeki   Martinetti Antonia   Seregni Ettore   Laterza Barbara   Oliva Daniela   Deraco Marcello  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2300-2308

Springer Publishing Company

Access to resources Recommend Favorite

Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy

By Yan Tristan   Sim Junyang   Morris David  

Annals of Surgical Oncology, Vol. 14, Iss. 6, 2007-06 ,pp. : 1807-1817

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Indicators for Patients Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma †

By Yan Tristan   Brun Erwin   Cerruto Carlos   Haveric Namik   Chang David   Sugarbaker Paul  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 41-49

Springer Publishing Company

Access to resources Recommend Favorite